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Abstract 
The transportation industry has the third highest occupational risk for death and disability (BLS, 
2010) with 7% of Commercial Motor Vehicle Drivers (CMVD) falling asleep while driving 
(NHTSA, 2006). One contributing factor may be undiagnosed Obstructive Sleep Apnea (OSA) 
(Tregear et al, 2009). In 2006, a Joint Task Force (JTF) published screening recommendations 
for OSA, which led to a change in the Department of Transportation screening practices within a 
local Occupational Medicine clinic.   
The purpose of this study was to:  (a) determine what percentage of drivers having had a positive 
clinical screening examination (met two of three objective measures) tested positive for a 
diagnosis of OSA (b) determine what percentage of drivers diagnosed with OSA had an Apnea-
Hypopnea-Index (AHI) greater than or equal to 20 abnormal breaths per hour, meeting the 
threshold for mandatory treatment, (c) determine the relationship between Body Mass Index 
(BMI), hypertension and neck circumference with a diagnosis of OSA.  
The electronic medical records of 182 drivers were reviewed. Of these, 143 were found eligible 
for the study with the following findings: 63% (n = 90) clinically screened positive and 
underwent confirmatory testing by Polysomnography (PSG). Of these, 92% (n = 83) were found 
to have OSA, and 48% (n = 43) met the threshold for mandatory treatment. The study found no 
correlation between a diagnosis of OSA and BMI.  Hypertension was found to have an inverse 
relationship. Neck circumference was found to have a significant positive correlation. No drivers 
self-reported daytime sleepiness and would have been missed using the current 
recommendations. Screening the CMVD for OSA with self-reported symptoms of sleepiness is 
not adequate.  This study shows the importance of neck circumference as the best predictor of 
identifying OSA.   
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Introduction 
 The Federal Motor Carrier Safety Administration (FMCSA) was established within the 
Department of Transportation (DOT) on January 1, 2000, pursuant to the Motor Carrier Safety 
Improvement Act of  1999 (49 U.S.C. 113). The primary mission of the FMCSA is to reduce 
crashes, injuries and fatalities involving large trucks and buses (FMCSA, 2014c). CMVD are 
required by the DOT to undergo a periodic medical fitness examination when operating a 
commercial vehicle in interstate commerce that meets three major requirements: (a) has a gross 
vehicle weight of 10,001 lbs, (b) is used for the transport of 16 passengers (whether for 
compensation or not), and (c) transports hazardous materials requiring placarding (FMCSA, 
2014a). The purpose of the medical examination is to detect any physical, mental, or organic 
conditions that may affect the ability of the driver to operate a commercial vehicle (FMCSA, 
2014b). One component of the 13 physical qualifications for drivers in the medical examination 
is evaluation of a diagnosed or suspected sleep disorder. Obstructive sleep apnea is a respiratory 
dysfunction that may affect driver’s alertness causing gradual or sudden incapacitation if the 
driver is drowsy or falls asleep (FMCSA, 2014b). It is a common sleep disorder and therefore the 
current focus for screening.      
Project Purpose 
 In 2012, a clinical practice change occurred within the occupational health clinic that 
affected how the CMVD was screened for obstructive sleep apnea. At the request of a single 
motor carrier company, the organization changed the existing screening policy to follow the Joint 
Task Force (JTF) consensus screening recommendation’s (Hartenbaum et al, 2006). Although 
not a requirement from the FMCSA, an employer may request additional screening beyond the 
DOT minimum for medical examiner to use.  The purpose of this project is to determine if 
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consensus based recommendations are an effective method for screening and increasing 
identification of drivers with suspected or unrecognized obstructive sleep apnea.  
Project Significance 
 Obstructive sleep apnea is a major contributor to sleepiness, a condition that could prove 
deadly for the commercial motor vehicle driver and passenger cars (Parks, Durand, 
Tsismenakis,Vela-Bueno, and Kales (2009); Tregear, Reston, Schoelles, and Phillips (2009).  
Parks et al. (2009) found obstructive sleep apnea to be a common health condition in the 
commercial driver, which if left untreated, has the potential to increase motor vehicle accidents 
by “two to seven fold” (p. 275).   
 Operating a large commercial motor vehicle is a multi-skilled task requiring a high level 
of physical, mental, and perceptual alertness (George, 2004). Drivers must be fully aware to 
critically analyze the surrounding area, make decisions quickly, and safely while maneuvering a 
large vehicle in difficult road conditions with limited road space (George, 2004). Due to the 
weight and size of a fully loaded truck or passenger bus the potential for destruction and harm is 
much greater than a passenger car (Donaghue and Labrum, 2014).  Undiagnosed or untreated 
obstructive sleep apnea, a serious factor in motor vehicle accidents (Platt et al., 2013), may cause 
lack of attention and somnolence while driving (Platt et al, 2013).   
 This study is significant because it may take years to federally legislate sleep apnea 
assessment in the commercial driver population due to the recent passage of the Sleep Apnea Bill 
H.R. 3095 (detailed in the Federal Register section).  The existing guidance is outdated, and 
recent recommendations are rescinded.  The commercial driver medical examiner, using 
professional decision-making, is left questioning which consensus material has the most value 
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when determining the risk for motor vehicle accidents.  The potential for serious and costly 
consequences may affect the commercial driver, the public and medical examiner equally (Strohl 
et al 2008; Boehlecke, B., 2008).  It is essential that medical providers have the knowledge and 
tools necessary to carry out the screening accurately and effectively with application to all 
drivers equally when presenting to the clinic utilizing the best evidence available to support 
public safety and the mission of the FMCSA.  
Current Screening Guidance 
 The current DOT medical screening guidance for commercial motor vehicle drivers that 
covers obstructive sleep apnea is in section 49 CFR 391.1 (b)(5) of the FMCSA regulations (see 
Appendix E). In this section, specific to the respiratory component of the medical exam, it states 
that the driver “has no established medical history or clinical diagnosis of a respiratory 
dysfunction likely to interfere with his ability to control and drive a motor vehicle safely” 
(FMCSA, p 4, section 5, 2014b).  However, the DOT does not have an absolute regulation on 
how the medical examiner should screen for respiratory conditions. The current guidance relies 
only on the patient’s perception and self-reports of a health condition.  
 Available for the medical examiners to reference are two Federal Highway 
Administration Conference reports from a 1991 conference on Respiratory/Pulmonary Disorders 
and Commercial Drivers (FMCSA-Medical Reports Archive) and a 1998 conference on 
Neurologic Disorder’s and Commercial Drivers (FMCSA-Medical Reports Archive).  In 2000, 
FMCSA added a new question to the medical history form asking the driver to self-report: (a) a 
diagnosed sleep disorder, (b) pauses in breathing while asleep, (c) daytime sleepiness or (d) loud 
snoring, further identifying a potential sleep disorder (FMCSA, 2014b).  The difficulty with self-
reporting a symptom such as snoring is the lack of awareness or recognition of a disease process, 
Ohlman, Dianna, UMSL, 2015 9 
 
which may be interpreted as a normal health behavior by the driver. Additionally the driver may 
fear reporting due to a concern about potential job loss with diagnosis of obstructive sleep apnea.  
Proposed Screening Guidance 
 To assist with the detection of obstructive sleep apnea a professional society Task Force, 
referred to as the Joint Task Force (detailed in the Review of Literature), published screening 
recommendations in 2006 to identify CMVD at high risk for obstructive sleep apnea 
(Hartenbaum et al, 2006). This Task Force included representatives of the American College of 
Chest Physicians (ACCP), the American College of Occupational and Environmental Medicine 
(ACOEM), and the National Sleep Foundation (NSF) (Hartenbaum et al, 2006). Following this 
publication in 2006 (detailed below), and challenged with the task of determining medical 
fitness, medical examiners requested updated guidance from the FMCSA (FMCSA, 2012).  To   
address these concerns the agency directed its two advisory committees, the Motor Carrier Safety 
Advisory Committee and the Medical Review Board to meet and provide recommendations 
(FMCSA, 2012).  In February 2012, the joint committee completed its consensus 
recommendations on obstructive sleep apnea and medical certification of the commercial motor 
vehicle driver (FMCSA, 2012). For the purpose of this study the Joint Task Force screening 
recommendations were utilized (detailed in the Measures section) (Hartenbaum, 2006).  
 The Joint Task Force recommended  drivers have additional testing if  they self-report a 
history of loud snoring, excessive daytime sleepiness, witnessed apneas, and or an Epworth 
Sleepiness Scale (ESS) score of greater than 10 (detailed in the Measures section and Appendix 
B), and a prior diagnosis or history of obstructive sleep apnea that is not adequately controlled. 
Additionally, they added recommendations for objective criteria including enlarged neck 
circumference, obesity and hypertension, which can be obtained through the history and physical 
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examination. The Task Force recommends further testing if the driver meets at least two of three 
objectively measured criteria (detailed in Appendix C).  
Federal Register 
 On April 20, 2012, the Federal Motor Carrier Safety Administration posted the proposed 
updated guidance from the Medical Expert Panel for public comment on the Federal Registry 
(FMCSA, 2012). The American Trucking Association (ATA) voiced objections about the 
Department of Transportation attempting to update recommendations and enact changes through 
guidance. In September 2012, two U.S. Representatives Larry Bucshon (R, Ind.) and Dan 
Lipinski (D-Ill.) introduced legislation to regulate standards for sleep apnea screening and testing 
of professional drivers (ATA, 2013).  As, ATA president and CEO Bill Graves said in an 
interview with PRNewswire,  
 “ATA believes that if the Federal Motor Carrier Safety Administration 
wants to regulate sleep apnea, it should do so through the normal, established 
regulatory process rather than informal guidance.  The rulemaking process 
allows for medical experts, the regulated community, including professional 
drivers, to provide valuable data and input for the agency to consider in 
developing its regulations. A formal rulemaking will also require an analysis 
of the benefits and costs of regulating sleep apnea, an analysis not required for 
the issuance of guidance.” (ATA, 2013).  
       The proposed guidance was subsequently withdrawn effective April 27, 2012 (FMCSA, 
2012).  The legislation introduced by U.S. Representatives Bucshon and Lipinski was the Sleep 
Apnea Bill H.R. 3095, which became law on October 15, 2013 (H.R. 3095, 2013).  The new 
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legislation ensures that any new or revised requirement by the Department of Transportation for 
sleep apnea be made by a formal rule making process and not guidance alone (H.R. 3095, 2013).  
       The rule making process may take years due to time and fund appropriations required to do the 
analysis.  
Epidemiology 
 Obstructive sleep apnea is a health condition known as a sleep-related breathing disorder. 
The condition involves a decreased or cessation of airflow with continued attempts to breath.  
Physiologically, muscles relax during the sleep period causing soft tissue in the back of the throat 
to collapse leading to a blocked upper airway (AASM, 2014). When this occurs, there is a partial 
reduction (hypopnea) or a complete pause (apnea) in breath for at least 10 seconds (AASM, 
2014).  Pauses can last for 10 to upwards of 60 seconds leading to decreased oxygen 
concentration in the blood (AASM, 2014). In more severe cases, oxygen levels can drop as much 
as 40 percent (AASM, 2008). The body’s normal response to the lack of oxygen is to alert the 
body causing a brief arousal from sleep to restore normal breathing. Many persons with 
obstructive sleep apnea snore loudly with frequent episodes of silence when the airflow is 
decreased or blocked.  Often persons make choking sounds, snorts or gasps for breath during 
sleep when trying to reopen the airway (AASM, 2014).   
 Obstructive sleep apnea is associated with reported symptoms of daytime sleepiness, 
decreased concentration and mood, headaches upon wakening, and snoring.  Other symptoms 
may include nocturnal choking, unrefreshed sleep, fatigue, and observed pauses in breathing 
while asleep by a bed partner and nocturia (Gharibeh & Mehra, 2010; AASM, 2014).    
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Prevalence of Disease 
 It has been estimated that as many as 18 million Americans have sleep apnea including 
17 to 28% of the commercial driving population (Pack et al, 2002; Talmage et al, 2008; Parks et 
al., 2009). Obstructive sleep apnea increased in 2014 to an estimated 25 million adults in the 
United States (AASM, 2014b).  Peppard, Young, Barnet, and Hia (2013), estimates the current 
prevalence for moderate to severe OSA with episodes of absent or reduced breath greater than 15 
events per hour are: (a) 10% among 30-40 year old men, (b) 17% among 50-70 year old men, (c) 
3% among 30-49 year old women and (d) 9% among 50-70 year old women.  These estimates of 
apnea have increased between 14-55% in keeping with the increase in overweight and obesity in 
the U.S. population (Peppard et al, 2013). Obstructive sleep apnea can occur at any age but 
prevalence increases during the middle and older years (AASM, 2008).  Large segments of the 
adult population, between 80 to 90 percent are estimated to have sleep apnea and remain 
undiagnosed (AASM, 2008).  
 The DOT regulates all registered commercial motor vehicles that operate interstate or 
carry hazardous materials. As of December 2013, there were approximately 539,000 commercial 
motor vehicles with recent activity operating in the United States.  Approximately 5.6 million 
commercial drivers operate in the United States, with a potential for 92,000 to 151,000 of these 
drivers having undiagnosed sleep apnea (FMCSA, 2014d).  Smith et al., (2011) reported in an 
online self-assessment that 21% of commercial drivers reported falling asleep at stoplights. This 
is in contrast, to responses from a Behavioral Risk Factor Surveillance System, an on-going 
United States telephone health survey, where nearly 5% of the general population reported at 
least once in the previous 30 days, they had fallen asleep or nodded off while driving (CDC, 
2012a).    
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Effects of Disease 
 The immediate effects of the disease are intermittent hypoxia, poor sleep, and fluctuating 
heart rhythm (Peppard et al, 2013). Decreased oxygen levels in the body can lead to decreased 
alertness, fatigue and impaired concentration (AASM, 2008). People with obstructive sleep 
apnea generally have an increase in cardiovascular disease, stroke risk and associated risk of 
increased impaired glucose tolerance and diabetes (Peppard et al, 2013; AASM, 2014). 
Untreated sleep apnea is a significant risk factor for developing hypertension independent of 
other conditions such as obesity and smoking (AASM, 2014). Lastly, there is an increased risk of 
injury and death related to an increase in motor vehicle accidents (Tregar et al, 2009).  
Risk Factors  
 Several identified risk factors may predispose someone to obstructive sleep apnea. Key 
factors for the development of this health condition are obesity, large neck and narrow airway. 
Other risk factors include: aging, menopause, being male, and alcohol consumption. Associated 
risks are craniofacial abnormalities, and genetics. Aging is associated with increased upper 
airway resistance, increased parapharyngeal fat, decreased parapharygeal size, and impaired 
muscle reflexes (Gharibeh & Mehra, 2010). Menopause due to the changes in body fat 
distribution, decreased upper airway muscle tone and decreasing hormonal influences are also 
considered risk factors (Gharibeh & Mehra, 2010; Lee, Nagubadi, Kryger, Mokhlesi  (2008). 
Obstructive sleep apnea is more common in men due to the difference in fat distribution. Men 
have more upper body fat including the neck and women have more lower body fat (Gharibeh & 
Mehra, 2010).  Alcohol ingestion prior to sleep has shown to increase the upper airway 
collapsibility resulting in increased disruption of sleep (Gharibeh & Mehra, 2010; Punjabi, 
2008).   
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 Craniofacial abnormalities that alter the bony and soft tissue structure of the head and 
neck may increase the risk of having sleep apnea (Gharibeh & Mehra, 2010). Genetically, there 
is a higher prevalence in families suggesting a familial component (Gharibeh & Mehra, 2010; 
AASM, 2014). Obesity is a significant risk factor.  Persons who are obese and morbidly obese 
have a higher prevalence of sleep apnea (Gharibeh & Mehra, 2010; AASM, 2014). Obesity has 
dramatically increased over the last 15 years in the United States, excess body weight is common 
in patients with obstructive sleep apnea (Lee et al, 2008). In 2013, there were approximately 
154.7 million Americans age 20 years and older who were overweight or obese in the United 
States. Men accounted for 79.9 million with a body mass index greater than 25 and women 
accounted for 74.8 million (AHA, 2013).  Excessive weight alters the upper airway by increasing 
parapharyngeal fat deposition resulting in a smaller airway and increased airway collapsibility, 
and reduction in lung volume. Clinically, excess body weight is present in more than 60% of 
sleep apnea patients (Gharibeh & Mehra, 2010; Lee et al, 2008; Punjabi, 2008). 
Relevance to Population Health Outcomes 
  Sleep problems are common; 25 % of U.S. adults report inadequate or poor quality sleep 
or rest at least 50% of the time (Healthypeople.gov, 2014). Insufficient sleep or poor sleep health 
has been associated with high blood pressure, coronary artery disease, cognitive impairment and 
increased occupational injury (Peppard et al, 2013).  Even mild and asymptomatic obstructive 
sleep apnea can produce sleepiness and place drivers at risk for increased motor vehicles 
accidents affecting the driver as well as other lives (Tregar et al, 2009).  
Initiatives  
 Obstructive  sleep apnea and the associated comorbid conditions can have a profound and 
costly impact on public health (Kapur, 2010).  Increased public awareness and treatment of sleep 
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health can improve productivity, wellness, quality of life, and safety on roads and in the 
workplace (Healthypeople.gov, 2014). One goal of Healthy People 2020 is to reduce the rate of 
vehicular crashes due to drowsy driving from 2.7 to 2.1 per 100 million miles traveled.  The 
American Academy of Sleep Medicine has collaborated with the Centers for Disease Control and 
Prevention to promote the National Healthy Sleep Awareness project educating the public that 
snoring is a warning sign of obstructive sleep apnea and encouraging adults to speak with their 
doctor (AASM, 2014b).    
Theoretical Framework 
  Rosswurm’s and Larrabee’s (1999) theory of change supports this project. This theory 
recognizes that translation of research into practice requires a solid grounding in change theory, 
principles of research utilization, and use of standardized language. The model for evidence-
based practice has the following six phases: (a) assess the need for change in practice by 
examining the current clinical screening practice of self-reported history compared to objective 
measures for obstructive sleep apnea; (b) link the problem with the interventions and outcomes 
by utilization of a Clinical Screening Tool to increase the recognition of obstructive sleep apnea 
through improved medical provider screening practices; (c) synthesize the best evidence by 
analytical review of the literature and research studies and utilization of the Joint Task Force 
screening recommendations; (d) design a change in practice with implementation of evidenced 
base care to improve patient outcomes; (e) implement and evaluate the practice change by 
adapting the Clinical Screening Tool for all commercial drivers presenting for the DOT medical 
examination; and (f) maintain change by continued use of the Clinical Screening Tool and 
referral of all commercial drivers meeting the screening criteria  
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            Rosswurm’s and Larrabee’s conceptual framework (1999) provides a rationale for 
empowering clinicians in the process of evidence-based practice changes. This model was used 
to adapt the existing medical evidence-based practice to incorporate a focus on nursing 
phenomena with the goal of teaching evidence based nursing practice, while also evaluating the 
possibility of changing clinical practice (Rosswurm & Larrabee, 1999). 
Review of the Literature 
 The keywords used to review the literature were obstructive sleep apnea and motor 
vehicle accidents, obstructive sleep apnea, and commercial drivers. The studies were reviewed to 
determine the prevalence of obstructive sleep apnea in the commercial driver population. The 
studies followed the screening recommendations from the Joint Task Force (detailed below) 
(Hartenbaum et al., 2006).  
 The Joint Task Force recommends: if the commercial driver meets two of three 
objectively identified criteria: (a) body mass index 35 kg/m
2
 or greater, (b) neck circumference 
greater than 17 inches in men and greater than 16 inches in women, (c) hypertension (new, 
uncontrolled, or unable to control with less than two medications) (Hartenbaum et al., 2006). 
Additionally, if the driver reports on the Medical Examination form a sleep history suggestive of 
obstructive sleep apnea: (a) a sleep disorder, (b) pauses in breathing while asleep, (c) daytime 
sleepiness, or (d) loud snoring. The Joint Task Force recommends referring the driver for an in-
lab sleep study also known as the polysomnography (PSG) (detailed in the Measures section).  
 Five studies reviewed indicated a high estimate of obstructive sleep apnea among cohorts 
of commercial drivers (Berger, 2012; Parks, 2009; Platt, 2013; Talmage, 2008; Xie, 2011).  
Talmage et al (2008) found of the 1,443 commercial drivers screened, 13% (n = 190) drivers 
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clinically screened positive by examination using the Joint Task Force recommendations. Of this 
71% (n = 134) underwent testing with the in-lab sleep study and 29% (n = 56) refused testing. Of 
the 71% (n = 134) that had testing, 95% (n = 127) were confirmed to have obstructive sleep 
apnea and 5% (n = 7) were not using the gold standard Polysomnography (detailed in the 
Measures section).  
 Talmage et al (2008) found that neck circumference clustered from 17-18 inches, the 
Epworth Sleepiness Scale scored 3-4 (range 0-24) (detailed in the Measures section) and 
hypertension was found in 40-60% of drivers diagnosed with moderate to severe obstructive 
sleep apnea. The most interesting findings were that none of the drivers would have been 
diagnosed if using the self-reported screening question on the current Medical Examination form 
by itself.   
 Parks et al (2009) found among 456 drivers in an occupational health clinic, 17% (n = 78) 
met the clinical screening exam recommendations of the Joint Task Force. Of this, 68% (n = 53) 
were referred for a sleep study and 32% (n = 25) were not due to examiner discretion. Of these, 
62% (n = 33) were lost to follow up leaving 38% (n = 20) of drivers accepting the voluntary 
testing. Of the 20 remaining drivers referred and tested, 20 were found to have a diagnosis of 
obstructive sleep apnea, supporting a high positive predictive value. The other 33 drivers that 
were lost to follow up showed no significant difference from those confirmed to have obstructive 
sleep apnea.   
 Platt et al (2013) screened 265 drivers, 14% (n = 36) were excluded for not meeting 
inclusion criteria, 35% (n = 92) declined to participate, leaving 52% (n = 137) drivers. Of the 
137 drivers enrolled in the study, 24% (n = 33) failed to follow up for testing. Of the remaining 
76% (n = 104) drivers, four failed the sleep study, which was not repeated. Of the remaining, 
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73% (n = 100) drivers successfully completed the sleep study with more than half (53%) found 
to have a diagnosis of obstructive sleep apnea and showing disease severity (AHI-detailed in the 
Measures section) of 20 or more episodes of absent or decreased breaths per hour, which is the 
required threshold for treatment. Using the current medical examination report form only 11% of 
the 100 drivers self-reported symptoms of sleepiness.   
 Berger et al (2012) conducted an employer mandated on-line screening for obstructive 
sleep apnea. The screening differed from Talmage (2008) and Parks (2009), in that a medical 
provider conducted no physical examination. The on-line screening found among 19,371 
Commercial Drivers, 30% (n = 5,908) were at higher risk. To date, 36% (n = 2,103) of drivers 
were sent for a sleep study (detailed in the Measures section) with 21% of these confirmed 
positive for a diagnosis of sleep apnea.  
  Xie et al (2011) conducted a medical records review and found among 1,833 drivers with 
no history of obstructive sleep apnea, 11% (n = 192) clinically screened positive. Of these, 60% 
(n = 127) failed to follow up and the remaining 79% (n = 51 of 65) were found positive for a 
diagnosis of obstructive sleep apnea after undergoing a sleep study. The study found only 3% (n 
= 50) self-reported a history of sleep condition.     
Cost of Crashes   
 In 2012 there were 89,000 large trucks and buses involved in injury crashes with 126,000 
people injured. There were 3,702 fatal crashes with 4,183 fatalities involving large trucks or 
buses, a five percent increase from 2011 (FMCSA, 2012d). The cost of police reported 
commercial motor vehicle crashes in 2011 totaled $87 billion dollars, of this $39 billion was 
attributed to fatal crashes, $32 billion to injury crashes and $16 billion to property damage only 
crashes (USDOT, 2013).  
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Joint Task Force  
 The JTF is a professional tri-society group composed of the American College of Chest 
Physicians (ACCP), the American College of Occupational and Environmental Medicine 
(ACOEM), and the National Sleep Foundation (NSF) (Hartenbaum et al, 2006). The ACCP is a 
medical specialty society of physicians, surgeons, allied health professionals, and individuals 
with PhD degrees who specialize in diseases of the chest and sleep disorders (ACCP, 2014). The 
NSF is an independent nonprofit organization dedicated to improving public health and safety by 
achieving understanding of sleep and sleep disorders, including sleep apnea (NSF, 2014a). The 
ACOEM is an international society of 4,500 occupational physicians and other health care 
professionals (to include Nurse Practitioners), providing leadership to promote optimal health 
and safety of workers, workplaces, and environments. The ACOEM professionals’ are trained in 
preventing illness and injury in the workplace, and in helping patients return to work (ACOEM, 
2014). The Joint Task Force is important because they created the tool with objective criteria that 
has a high predictive value for Obstructive Sleep Apnea diagnosis.  
Summary of Literature Review 
 Commercial motor vehicle accidents remain a major occupational health and economic 
issue. Many of these accidents could be related to drowsiness or lack of attention while driving 
which may be attributable to obstructive sleep apnea. The reviewed studies show significant 
problems in the current screening process. Overwhelmingly, a large number of drivers lack 
recognition of or fail to report symptoms of sleepiness. The lack of confirmatory tests and return 
to the medical examiner following referral for a sleep study (PSG-detailed in the Measures 
section) reveals a significant gap in the screening and subsequent diagnostic process. In addition, 
more than half of the drivers failed to return to the medical examiner following the screening 
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examination because there was no mandated requirement to do so (Berger, 2012; Parks, 2009; 
Platt, 2013; Talmage, 2008; Xie 2011). The studies show a high predictive value upward of 80% 
with application of the Clinical Screening Tool using objective criteria recommended by the 
Joint Task Force with confirmation of the apnea diagnosis by a sleep study. These studies 
confirm that the Epworth Sleepiness Scale (detailed in the Measures sections) is not adequate to 
identify sleep apnea in a commercial driving population with few to none reporting sleepiness.   
Clinical Application and Need for the Study 
 All commercial drivers in the United States are required to complete a medical 
examination every two years in order to maintain their license. Drivers with a diagnosis of sleep 
apnea and other chronic diseases are required to renew every year. During this required medical 
examination, the commercial driver presents to the occupational medicine clinic and completes 
the Medical Examination Report Form for Commercial Driver Fitness Determination (Appendix 
D). The driver self-reports his/her medical history and demographic information onto the form. 
The driver self-reports daytime sleepiness onto the Epworth Sleepiness Scale (detailed in the 
Measures section). The medical assistant measures the driver’s blood pressure, height and weight 
and then calculates the body mass index. The medical assistant then measures the driver’s neck 
circumference with an elastic tape measure and records all findings onto the Clinical Screening 
Tool.  
 The medical examiner reviews the medical history form with the driver, then reviews the 
measures obtained by the medical assistant and performs a physical examination on the driver. 
The medical examiner, after review of the information and physical exam, determines if the 
driver meets the Joint Task Force criteria (see Measures section) for additional screening for 
sleep apnea. Drivers with suspected sleep apnea are issued a temporary medical certificate of 
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clearance or denied a medical certificate and referred for an in-lab sleep study (PSG-detailed in 
the Measures section). The medical clearance is reviewed after the sleep study results are 
provided to the medical examiner for decision making and extended medical clearance. The 
driver requires medical intervention if the results of the sleep study showed an AHI (Apnea-
Hypopnea-Index-detailed in the Measures section) greater than or equal to 20 abnormal breaths 
per hour.   
 The aim of this study is to demonstrate that subjective self-reported measures alone are 
inadequate to screen the commercial driver for suspected obstructive sleep apnea. A second aim 
is to show the effectiveness of adding objective criteria to the examination process for a 
suspected obstructive sleep apnea condition with the goal of diagnosis through an in-lab sleep 
study. Figure 1 is a diagram describing the clinic process from the time the driver presents for the 
DOT examination through the medical examination. 
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Figure 1.  Clinic Process 
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Research Questions 
1.  What percentage of drivers having had a positive clinical screening examination (met two of 
three objective measures) tested positive for a diagnosis of obstructive sleep apnea? 
2. What percentage of drivers diagnosed with obstructive sleep apnea had an Apnea-Hypopnea-
Index (AHI) greater than or equal to 20 abnormal breaths per hour, meeting the threshold for 
mandatory treatment? 
3. What is the relationship between body mass index, hypertension and neck circumference with 
a diagnosis of obstructive sleep apnea? 
Methodology  
Plan of Study 
 This was a retrospective, exploratory and correlational study. The project was designed to 
determine if the implementation of a Clinical Screening Tool (detailed in the Measures section 
and Appendix B) with objective measures would increase detection of drivers with obstructive 
sleep apnea compared to subjective, self-reported symptoms of sleepiness alone. The investigator 
reviewed, analyzed and interpreted 143 electronic medical records of commercial drivers 
presenting to three occupational medicine clinics for the DOT medical exam. The record 
assessment included: self-reported history of sleepiness, objective physical characteristics 
obtained from the medical examination, sleep study results and demographics (detailed below in 
Measures section).   
The study was designed to determine: (a) how many commercial drivers having had a 
positive clinical screening examination (met two of three objective criteria which included body 
mass index, hypertension, or neck circumference), tested positive for a diagnosis of obstructive 
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sleep apnea (b) how many commercial drivers diagnosed with obstructive sleep apnea had 
disease severity greater than 20 (measured by the AHI detailed in the Measures section), meeting 
the threshold for mandatory treatment, and (c) the relationship between a diagnosis of obstructive 
sleep apnea with body mass index, hypertension and neck circumference.   
Setting and Sample 
 The setting for this project was an occupational medicine practice in the mid-west with 
three clinic locations that are part of a larger healthcare system. The sample subjects were 
commercial drivers from a single transportation company who underwent the mandated DOT 
medical examination utilizing the addition of the Clinical Screening Tool. The subjects were 
obtained from the Electronic Medical Record (EMR) search from January 1, through December 
31, 2012 of drivers presenting for the DOT medical examination.  
Protection of Human Subjects 
 Permission to begin the project was first obtained from the Vice President of the research 
site where the data was stored since the company did not have an Institutional Review Board 
(IRB). Permission was then obtained from the IRB of the University of Missouri-St. Louis before 
data collection began. This study involved the use of existing data from the EMR of drivers that 
underwent the DOT medical examination.  The investigator only reviewed the section of the 
medical record that pertained to this study. All information has been reported in aggregate 
fashion; individual subjects are not identifiable in the report. Data was de-identified by 
eliminating any potentially identifying information and assigning the subject a unique numerical 
identifier.  
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Procedure for Data Collection 
 The data were collected using a retrospective review of charts within an electronic 
medical records system.  This was a pilot study looking at drivers with a high risk for obstructive 
sleep apnea. The investigator contacted the system analyst at the research site requesting records 
retrieval. The systems analyst provided the names of 182 drivers meeting the study criteria as 
follows: (a) a commercial driver that presented only one time for the Department of 
Transportation medical examination between January 1
st
, 2012 through December 31
st
, 2012, (b) 
the driver was employed by a single transportation company that requested application of the 
Clinical Screening Tool and, (c) the driver was issued a one month or less medical clearance, 
indicating a need for further medical evaluation.  
 The data from 182 records were de-identified by assignment of a unique numerical 
identifier. The patient name and unique identifier were transcribed onto a master list, and locked 
in a file at the research site, to which only the investigator had access. Subjects were completely 
anonymous; no information stored for analysis can be directly linked back to the patient record. 
No personal or medical information was directly linked to a patient name.  
 The study was designed to assess the effectiveness of a Clinical Screening Tool to detect 
drivers at higher risk for obstructive sleep apnea. Therefore, drivers with a prior history of 
having sleep apnea were excluded from the study. Other exclusions included: (a) did not meet 
the clinical screening criteria (having met two of three objective criteria-detailed in the Measures 
section), (b) lost to follow up, (c) excluded for other health conditions that would of themselves 
be disqualifying such as cardiovascular instability, uncontrolled diabetes or blood pressure 
greater than or equal to 180/110. The remaining drivers were divided into two groups. The first 
group consisted of drivers testing negative for a diagnosis of obstructive sleep apnea with disease 
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severity of less than five abnormal breathing events per hour (determined by the AHI-detailed in 
the Measures section). The second group of drivers were those that had a positive diagnosis for 
obstructive sleep apnea with disease severity of greater than or equal to five abnormal breathing 
events per hour (from the AHI-detailed in the Measures section). The latter group required 
mandatory treatment for OSA. 
 Demographic data collected were age and gender. Biophysical characteristics collected 
were; body mass index, blood pressure, neck circumference, and sleep study result (described in 
Measures section below). The investigator entered the de-identified data manually into an Excel 
spreadsheet. At the completion of the data collection, the de-identified data were then transferred 
to a secured flash drive for statistical analysis by SPSS Statistics, Version 22. The analysis was 
conducted with assistance from the University of Missouri-St. Louis, College of Nursing Senior 
Research Assistant.  
Measures 
Self-Reported History (subjective measure) 
 The driver was asked to report the following conditions on the medical examination 
form: (a) a past or current history of a sleep disorder, (b) pauses in breathing while asleep, (c) 
daytime sleepiness or, (d) loud snoring. Additionally, the driver reported any at-fault commercial 
motor vehicle accidents related to sleepiness or a witnessed apnea. For this study, the 
investigator reviewed the medical exam history form completed and signed by the driver and 
recorded findings onto the Excel spreadsheet.  
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Epworth Sleepiness Scale (subjective measure) 
 The Epworth Sleepiness Scale (ESS) is commonly used in the field of sleep medicine. It 
is a simple, self-administered eight-item questionnaire (see Appendix A).  The tool was 
developed to measure self-reported daytime symptoms that persisted from week to week for 
clinical patients. Each item is scored from 0-3 describing recent patterns of dozing or chances of 
falling asleep. Scores can range from 0-24 on the 8-item questionnaire. A sum of greater than ten 
can indicate excessive sleepiness in clinical populations and consideration should be given for 
additional evaluation (Johns, 1991). For this study, the driver completed the 8-item questionnaire 
prior to the examination; questions were clarified by the medical examiner as part of the clinic 
protocol. The investigator reviewed the hand scored questionnaire signed by the driver, included 
it as part of the medical record and recorded the findings onto the Excel spreadsheet.    
Neck Circumference (objective measure) 
 Neck circumference has shown to be a predictor of obstructive sleep apnea (AASM, 
2014). It has been observed that persons with obstructive sleep apnea tend to have a shorter and 
fatter neck than those without. Obesity may contribute to a large neck due to the weight 
proportion of fatty tissue (Katz et al, 1990). As weight increases, the neck circumference gets 
thicker. The increased level of fat in the posterior throat causes a narrowing of the airway, which 
increases the risk for blockage (AASM, 2010). Men with a neck circumference greater than 17 
inches and females greater than 16 inches are at greatest risk for obstructive sleep apnea 
(Hartenbaum et al, 2006). For this study, neck circumference was obtained by the medical 
assistant during the examination using an elastic tape measure and recorded on the Clinical 
Screening Tool. The investigator reviewed this documentation in the EMR and recorded the 
findings onto the Excel spreadsheet. 
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Body Mass Index (objective measure) 
 Body Mass Index (BMI) is a measurement that standardizes the height to weight ratio.  
Calculating the index is the first step to determine the degree of obesity.  BMI is expressed as 
weight in kilograms divided by height in meters squared (kg/m2). Calculation of the BMI is 
commonly used to classify overweight (BMI of 25.0-29.9), obesity (BMI greater than or equal to 
30.0), and extreme obesity (BMI greater than or equal to 40.0) (CDC, 2012b). Adults with a BMI 
greater than 30 have been found to have an increase in obstructive sleep apnea, the severity of 
disease increases with amount of excess weight (Lee et al, 2008; AASM, 2014). The Joint Task 
Force uses the cut-off point of BMI greater than 35 for identifying higher risk of sleep apnea 
(Hartenbaum, 2006). For this study, the medical assistant measured and then entered the drivers’ 
current height and weight into the electronic medical record, which then calculated the BMI. The 
BMI was than transcribed onto the Clinical Screening Tool by the medical assistant. The 
investigator reviewed and recorded the findings onto the Excel spreadsheet.   
Hypertension (objective measure) 
 Hypertension is the amount of fluid pushing against the walls of the arteries that carry 
oxygen in the body.  There is an associated risk between obstructive sleep apnea and 
cardiovascular indicators such as high blood pressure and heart failure (National Sleep 
Foundation, 2004). It has been estimated that between 30-40% of adults diagnosed with 
obstructive sleep apnea have high blood pressure (AASM, 2014). During sleep apnea episodes 
when breathing is compromised, oxygen levels drop and the brain instinctively sends a signal 
telling the blood vessels to tighten up in order to increase oxygen to the heart and brain resulting 
in high blood pressure (National Sleep Foundation, 2004). For this study, the medical assistant 
using an electronic sphygmomanometer obtained the blood pressure measures twice. There is no 
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record reporting how far apart in minutes the blood pressure was retaken by the assistant. The 
results were then hand written onto the medical examination form as well as the Clinical 
Screening Tool. The investigator retrospectively reviewed both the Clinical Screening Tool and 
the Medical Examination form to ensure accuracy of recording. If the numbers were different, 
the investigator recorded the lower of the two readings onto the Excel spreadsheet.  
Polysomnography, In-lab Sleep Study (objective measure) 
 Objective testing for apnea can be conducted in the home with a home sleep test or in a 
sleep center under observation of a sleep technologist. The current gold standard for diagnosing 
and determining severity of obstructive sleep apnea is the in-laboratory, technologist attended 
Polysomnography (PSG), also described as an attended or in-lab sleep study. The PSG measures 
brain waves, airflow, heart rate and rhythm, and respiratory effort. It also records eye 
movements, limb movements and oxygen in the blood (AASM, 2014a). During an over-night 
attended sleep study, a sleep technologist observes and monitors these measures. The collected 
data were reviewed and interpreted by a physician to make a diagnosis of obstructive sleep apnea 
using the Apnea-Hypopnea-Index as a reference (AASM, 2014a). For this study, the investigator 
reviewed the sleep study results from the sleep lab, which indicated disease or no disease, based 
on the gold standard testing method, and recorded the findings onto the Excel spreadsheet. The 
following measures of abnormal breathing events are obtained from the in lab sleep study: 
 (a) Episodes of Apnea (objective measure) 
  Apnea is the temporary cessation of breathing and therefore, of the body’s intake of 
oxygen and release of carbon dioxide. It is a serious symptom, especially in patients with other 
potentially life-threatening conditions (Venes, 2013). 
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(b) Episodes of Hypopnea (objective measure) 
 Hypopnea is a respiratory disorder that involves a decrease in rate and depth of breathing 
in an individual (Venes, 2013).  
(c) Episodes of Apnea-Hypopnea-Index (objective measure) 
 At the completion of the Polysomnography, also known as the sleep study, the data is 
reviewed to determine the Apnea-Hypopnea-Index (AHI), which is commonly used to establish 
the objective diagnosis of obstructive sleep apnea (Hartenbaum et al 2006 p. S6). AHI is defined 
as the sum of apneas and hypopneas divided by the hours slept (Hartenbaum et al 2006 P S6; 
AASM 2014). The Apnea-Hypopnea-Index (AHI) measures disease severity. Mild obstructive 
sleep disease is measured by an AHI between 5-15 abnormal breathing events per hour, 
moderate obstructive sleep disease is an AHI between 15-30 abnormal breathing events per hour 
and severe sleep disease is an AHI greater or equal to 30 abnormal breathing events per hour 
(AASM, 2008).  
 For this study, the certified sleep lab obtained the Apnea-Hypopnea-Index for each 
participant. A physician then interpreted the results and made a diagnosis if indicated, and a 
medical report was faxed to the occupational medicine clinic for scanning and storage in the 
drivers’ medical record. The investigator reviewed the report findings and manually entered the 
AHI onto the Excel spreadsheet.   
Clinical Screening Tool (known within the clinic as the DOT Sleepiness Risk Assessment Tool) 
 The DOT Sleepiness Risk Assessment Tool (Appendix B) used in this study for the 
detection of a sleep disorder was adopted by the Occupational Medicine clinic that was the site 
for this clinic. The tool was created based on recommendations from the Joint Task Force 
Consensus Recommendations (see Appendix B). The assessment tool was used as a worksheet 
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by the Occupational Medicine clinic for the detection of commercial drivers at higher risk for 
obstructive sleep apnea.  The Task Force recommended referring a driver for additional 
screening if two of three objective criteria are met: (a) body mass index 35 kg/m
2
 or greater, (b) 
neck circumference greater than 17 inches in men and greater than 16 inches in women, and (c) 
hypertension (new, uncontrolled, or unable to control with less than two medications) 
(Hartenbaum et al., 2006). The blood pressure cut off for this study was equal or greater to 
140/90. In addition, subjective measures of sleepiness were assessed (detailed in the Measures 
section). When the driver self-reports on the Medical Examination Form a sleep history 
suggestive of obstructive sleep apnea; a sleep disorder, pauses in breathing while asleep, daytime 
sleepiness, loud snoring or an Epworth Sleepiness Scale greater than or equal to ten  (detailed in 
the Measures section and Appendix C), referral for additional objective assessment is 
recommended.   
Results 
Sample 
  One hundred eighty-two electronic health records from January 1, 2012 to December 31, 
2012 were reviewed. Of the 182 records, 39 (21%) were excluded for disqualifying health 
conditions such as cardiovascular instability, uncontrolled diabetes, or blood pressure greater 
than or equal to 180/110. Of the remaining 143 drivers, 31 (22%) were excluded for prior history 
of obstructive sleep apnea (detailed in the Procedure for Data Collection section). Of the 
remaining 112 records, five (3%) were excluded for not meeting the clinical screening cut-offs 
(having met two of three objective measures recommended by the Joint Task Force). Two (1%) 
were excluded for missing data.  Of the remaining 105 records, 15 (10%) were excluded due to 
loss of follow up, leaving 90 (63%) commercial drivers for final evaluation. Of the remaining 90 
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participants, none of the drivers self-reported symptoms of sleepiness or had an Epworth Sleep 
Score above ten (detailed in the Measures section). Of the 143 drivers, 90 (63%) were included 
in the final analysis and referred for confirmatory testing by Polysomnography or in-lab attended 
sleep study. These drivers would have otherwise been missed using the existing screening 
criteria of self-reported symptoms of a sleep disorder. Figure two is a diagram detailing the 
subjects that were reviewed in this study. 
Figure 2. Study Subjects  
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Data Analysis 
 The study sample consisted of 26% (n = 23) females and 74% (n = 67) males. The mean 
age of the commercial driver was 46 years with a standard deviation of 10.3. The mean Epworth 
was 1.73 and the standard deviation was 0.872.  No driver self-reported a sleep disorder, pauses 
in breathing while asleep, daytime sleepiness, or loud snoring.  The investigator ran descriptive 
and correlational analyses using IBM SPSS Statistics Data Editor Version 22. The data analysis 
addressed the following questions: 
 Research  Question 1. What percentage of drivers having had a positive clinical 
screening examination (met two of three objective measures) tested positive for a diagnosis of 
obstructive sleep apnea?  
 The investigator ran a descriptive analysis comparing drivers with a sleep study result of 
less than five abnormal breaths per hour indicating no sleep apnea to those greater than or equal 
to five abnormal breaths per hour indicating a positive finding of obstructive sleep apnea 
(detailed in Measures section). Of these drivers, 8% (n = 7) were found not to have obstructive 
sleep apnea and 92% (n = 83) were found to have a diagnosis of obstructive sleep apnea. For this 
study, the driver received a diagnosis of obstructive sleep apnea if the Apnea-Hypopnea-Index 
was greater than or equal to five abnormal breaths per hour (detailed in the Measures section). 
Diagnosis of apnea is determined by the severity of disease. This study found: (a) 31% of (n = 
28) drivers with mild sleep apnea (measuring between 5.0-14.99 abnormal breaths per hour), (b) 
41% (n = 37) of drivers with moderate sleep apnea (measuring between 15.0-29.0 abnormal 
breaths per hour), and (c) 20% (n = 18) of drivers with severe sleep apnea (measuring at greater 
than or equal to 30 abnormal breaths per hour).   
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Research Question 2.  How many commercial motor vehicle drivers diagnosed with obstructive 
sleep apnea had an Apnea-Hypopnea-Index greater than or equal to 20 abnormal breaths per hour 
meeting the threshold for mandatory treatment? 
 The investigator ran a descriptive analysis comparing drivers with sleep study results less 
than 20 abnormal breaths per hour (AHI) to those equal or greater than 20 abnormal breaths per 
hour (AHI).  Of these 63% (n = 90) drivers met the clinical screening criteria (having met two of 
three objective measures) 48% (n = 43) met the threshold for mandatory treatment and 52% (n = 
47) did not meet the threshold required for treatment.   
Research Question 3.  What is the relationship between body mass index and a diagnosis of 
obstructive sleep apnea?  
 In order to test the relationship between body mass index and a diagnosis of obstructive 
sleep apnea, a Pearson correlation was calculated. The calculation found no significant 
association between a diagnosis of disease and body mass index.    
Research Question 4. What is the relationship between hypertension (using systolic and 
diastolic blood pressure as a measure) and a diagnosis of obstructive sleep apnea? 
 In order to test the relationship between a diagnosis of obstructive sleep apnea and 
systolic and diastolic blood pressure, a Pearson correlation was calculated. Systolic blood 
pressure was found to have an inverse relationship of -.235 and was significant at the .01 level. 
Diastolic blood pressure was not found to have a significant relationship.  
Research Question 5. What is the relationship between neck circumference and a diagnosis of 
obstructive sleep apnea? 
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 To test the relationship between neck circumference and obstructive sleep apnea a 
Pearson Correlation test was calculated. The calculation found a correlation of .275 significant 
at the 0.01 level (2-tailed).   
Summary of Results 
 The study found 63% (n = 90) of drivers clinically screened positive using objectives 
measures and of those 92% (n = 83) were diagnosed with obstructive sleep apnea. These drivers 
would have otherwise been missed using the current criteria of subjective measures alone. Close 
to half of the drivers, 48% (n = 43) required mandatory treatment following the FMCSA 
advisory board recommendations. The study found no correlation between a diagnosis of 
obstructive sleep apnea and body mass index or diastolic hypertension. Systolic hypertension 
was found to have a significant inverse relationship. Neck circumference was found to have a 
significant positive correlation further supporting adoption of this measure to screen the 
commercial driver for sleep apnea. Neck circumference is the best predictor of obstructive sleep 
apnea.   
Stakeholders 
 The key stakeholders of this project include the commercial driver who presents for the 
annual Department of Transportation medical certification, the certified medical examiner 
performing the examination, the private companies that employ the driver, and the occupational 
medicine clinic.  Other stakeholders include the families of the drivers affected financially from 
testing and diagnosis, sleep centers performing the testing, and the insurance companies paying 
for the testing and supplies.  
Ohlman, Dianna, UMSL, 2015 36 
 
  Others involved in the operations are the medical director, responsible for the leadership 
and care provided by the individual medical providers, the clinic director, who directs the clinic 
staff and has the responsibility of responding to Client Company and driver concerns. The 
primary care provider who manages the driver’s disease is a stakeholder. The public, sharing the 
highways and roadways with the commercial drivers, are stakeholders due to accidents and 
potential fatalities.  Occupational Medicine organizations that represent and provide guidance for 
the profession are stakeholders in the findings of a sleep apnea project.   
Outcomes  
 The short-term outcome for this project is the application of the Clinical Screening Tool  
(Appendix C) for identification of drivers meeting the Task Force consensus recommendations 
for additional screening if meeting two or more risk factors for Obstructive sleep apnea 
(Appendix C & D).  For this project the Joint Task Force recommendations are; (a) Body Mass 
Index 35 kg/m
2
  or greater, (b) neck circumference greater than 17 inches in men and greater 
than 16 inches in women, (c) hypertension (new, uncontrolled, or unable to control with less than 
2 medications),  (Hartenbaum et al., 2006). The driver self-reports on the Department of 
Transportation medical examination form a sleep history suggestive of obstructive sleep apnea, 
or an Epworth Sleepiness score greater than ten (detailed in the Measures section).  An 
intermediate outcome for this project is the referral of the commercial driver for objective testing 
and identification of drivers with Apnea-Hypopnea-Index greater than 20 abnormal breaths per 
hour (detailed in the Measures section).  The long-term goal of this project is to develop a 
continuous high quality-screening program.   
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Limitations  
 This was a pilot study looking at high risk drivers within a single transportation company. 
The sample size was small with little variation in characteristics between subjects due to the high 
risk population. Limitations of the study included inability to verify the reliability of the data that 
was hand written on the Clinical Screening Tool. The investigator did not directly collect the 
data and the study relied on others who collected and entered the data into the EMR. Due to 
limitations of the electronic medical record, it was not possible to electronically search for the 
individual variables for the study. The investigator was the only one who reviewed the medical 
records and recorded the data so reliability could not be assessed. The investigator manually 
entered the data into the Excel spreadsheet, which was not verified for accuracy by another 
investigator. In this study 10% (n = 15) were lost to follow up so it is unknown if they would 
have been diagnosed with Obstructive Sleep Apnea.  
Discussion 
 In summary, the study shows subjective reports of sleepiness are inadequate with none of 
the drivers reporting sleep symptoms on the Medical Examination Form. The Epworth 
Sleepiness Scale is ineffective for screening for obstructive sleep apnea in this population with a 
low mean of 1.73 and restricted standard deviation of 0.9. None of the drivers scored above 10, 
which is the cut-off for referral and diagnostic testing based on JTF recommendations. The 
clinical screening with objective criteria found 92% (n = 83) of drivers that would have been 
missed if using the current guidance of subjective measures alone or the current FMCSA medical 
evaluation form. Of these, 48% (n = 43) met the threshold for mandated treatment. Additionally, 
52% (n = 47) tested positive for a diagnosis of obstructive sleep apnea but did not meet the 
threshold for treatment; however they will require annual monitoring due to having the disease. 
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This study found a moderate correlation of .28 between a diagnosis of obstructive sleep apnea 
and neck circumference significant at the .01 level. There was no correlation between body mass 
index with a diagnosis of obstructive sleep apnea. Systolic hypertension showed a moderate 
inverse relationship of .28. This was an unexpected finding and concurrent treatment for 
hypertension may have been a confounding factor.  62% (n = 56) of the drivers reported 
receiving prescriptions for one or more medications which may have controlled the systolic, 
diastolic or both blood pressures when presenting for the medical examination.  
 Body mass index was not a good indicator for a diagnosis of obstructive sleep apnea 
according to this study. This may be due to the small sample size or possible restriction of range 
for this variable. This also may be due to people carrying their excess weight in different areas, 
often described as the apple or pear shaped figure. The Body mass index is a calculation of 
height and weight, but it does not account for people’s weight distribution and those who carry 
more muscle weight and others who carry more fat weight. Neck circumference is definitely the 
more consistent predictive measure. Adding the neck circumference to the Department of 
Transportation medical examination does have value and needs implementation along with 
objective measures already collected such as height, weight, and blood pressure to detect drivers 
with under recognized and undiagnosed obstructive sleep apnea. This study supports the addition 
of neck circumference as part of the Department of Transportation medical exam process to 
identify drivers at high risk for obstructive sleep apnea.   
Application to Practice 
 The goal of this project is to apply and sustain a change in practice applicable to all 
drivers presenting to the occupational medicine clinic. The knowledge gained from the 
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retrospective EMR review will help support the practice change and utilization by all 
Occupational Medicine providers.     
 Dissemination of the project information and findings will be available through the 
Occupational Medicine website and monthly newsletter for employers and employees to utilize 
as a resource.  Presentations will be given at the local and state Nurse Practitioner meetings, 
National Conferences and the National Occupational Medicine conference. On presentation 
attention will be given to the lack of current guidance at the Federal level to support expedited 
change in practice for clinicians to utilize.  
DNP Essentials 
 The Doctor of Nursing Practice (DNP) education allows nurses to develop into clinical 
experts and leaders in nursing practice. The eight essentials are defined by the American 
Association of Colleges of Nursing in 2006 (AACN, 2006). The essentials incorporate advanced 
education and training in the areas of science, organizational systems, clinical scholarship, 
informatics, health care policy, interprofessional collaboration to improve patient and population 
health, clinical prevention and advanced nursing practice (AACN, 2006) (see Table 1). This 
project meets the criteria for the 8 essentials of Doctoral Education for Advanced Nursing 
Practice as defined by the American Association of Colleges of Nursing (Appendix E).  
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 Appendix A 
Epworth Sleepiness Scale 
__________________________________________________________________________________ 
Use the following scale to choose the most appropriate number for each situation: 
0 = Never doze or sleep 
1 = Slight chance of dozing or sleeping 
2 = Moderate chance of dozing or sleeping 
3 = High chance of dozing or sleeping 
 
 
 
Situation  Chance of 
dozing or sleeping 
 
 
Sitting and reading 
 
 
Watching TV 
 
 
Sitting inactive in a public place 
 
 
Being a passenger  in a motor vehicle 
for an hour or more 
 
 
Lying down in the afternoon 
 
 
Sitting and talking to someone      
Sitting quietly after lunch (no alcohol)  
 
Sitting quietly after lunch (no 
alcohol) 
 
Stopped for a few minutes 
in traffic while driving 
 
 
Total score 
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 Appendix B 
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 Appendix C 
 
Logic Model 
 
Inputs Activities Outputs Short Term 
Outcomes 
Mid-Term 
Outcomes 
Long-Term 
Outcomes 
 
Stake 
holder 
 
CMVD 
 
Medical 
examiner 
 
Employer 
(Client 
Company) 
 
Research 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Identify  
Stake 
holders 
 
Request 
approval 
from 
research site 
 
Request IRB 
permission 
 
Apply JTF 
criteria  
 
Measure 
neck  
 
Calculate 
BMI 
 
Measure 
blood 
pressure 
 
Record 
gender 
 
Complete 
medical 
forms 
(driver) 
 
Refer  PSG 
 
 
 
Complete 
retrospective 
chart review 
 
Compare self-
reports of 
sleepiness to 
objectively 
measured sleep 
 
Analyze data 
 
PSG performed 
 
 
Clinical 
screening tool 
applied 
 
Identification 
of at risk 
CMVD 
 
Driver 
referred  
 
Objectively 
tested 
 
Identify 
drivers with 
AHI > 20 
 
Increase 
driver 
knowledge  
 
Develop a 
continuous 
high quality 
screening 
program 
 
Develop 
Educational 
program 
 
Improved 
health of driver 
 
 
 
 
 
Ohlman, Dianna, UMSL, 2015 50 
 
 
Ohlman, Dianna, UMSL, 2015 51 
 
 Appendix D 
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Appendix E 
The Essentials of Doctoral Education for Advanced Nursing Practice 
Evidence of Completion 
DNP Essentials Evidence from DNP Project 
Scientific Underpinnings for 
Practice 
Integrated nursing science and Rosswurm & Larrabee’s 
(1999) theory of change to support a clinical practice 
change, screening the CMVD for unrecognized OSA, a 
significant public health issue. 
Organizational and Systems 
Leadership for Quality 
Improvement and Systems Thinking 
Conducted organization and medical provider meetings to 
determine interest and gain support for the DNP 
investigation and quality improvement project. 
Clinical Scholarship and Analytical 
Methods for Evidence-Based 
Practice 
Analytical review of literature and research studies.   
Information Systems/Technology 
and Patient Care Technology for the 
Improvement and Transformation of 
Health Care 
Demonstrated technical skills to develop and execute an 
analysis involving data extraction from practice 
information and database. 
Health Care Policy for Advocacy in 
Health Care 
Engaged in the development and implementation of health 
care policy at the institutional level. This has helped to 
alleviate the fragmentation of healthcare and systems 
failure with lack of screening and recognition of OSA by 
the primary care provider.  
Interprofessional Collaboration for 
Improving Patient and Population 
Health Outcomes 
Collaborated with organizational leadership, physicians, 
clinic staff and specialty sleep centers to advance the 
health of the CMVD to create change in healthcare 
delivery. Facilitated interprofessional communication and 
educated about the role of the DNP.   
Clinical Prevention and Population 
Health for Improving the Nation’s 
Health 
The project supports Healthy People 2020 to reduce the 
rate of vehicular crashes due to drowsy driving and the 
National Healthy Sleep Awareness project. 
Advanced Nursing Practice Demonstrated advanced clinical judgment and systems 
thinking, evidenced by designing and implementing 
evidence-based care to improve patient outcomes. 
Integrated conceptual and analytical skills evaluating the 
links among practice, organizational ,population and 
policy issues.   
 
 
